HeartHero Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $7.75M

  • Investors
  • 4

HeartHero General Information

Description

Developer of an automated external defibrillator (AED) intended to empower anyone, anywhere to save a life from sudden cardiac arrest. The company's defibrillator is a portable, easy-to-use device powered by a store-bought battery. It can automatically diagnose life-threatening cardiac arrhythmias, including ventricular fibrillation (VF) and pulseless ventricular tachycardia, and treat them through defibrillation, enabling patients to receive help during sudden cardiac arrest.

Contact Information

Formerly Known As
EIR
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3200 Cherry Creek South Drive
  • Suite 470
  • Denver, CO 80209
  • United States
+1 (720)
Primary Industry
Other Devices and Supplies
Other Industries
Therapeutic Devices
Corporate Office
  • 3200 Cherry Creek South Drive
  • Suite 470
  • Denver, CO 80209
  • United States
+1 (720)

HeartHero Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HeartHero Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 09-Feb-2026 $7.75M Completed Generating Revenue
4. Later Stage VC 08-Aug-2023 Completed Generating Revenue
3. Early Stage VC (Series A) 06-Aug-2019 Completed Generating Revenue
2. Early Stage VC (Series AA) 21-Sep-2018 $2.67M $2.67M Completed Startup
1. Grant 18-May-2018 $250K Completed Startup
To view HeartHero’s complete valuation and funding history, request access »

HeartHero Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Series AA
Series AA-1 1,312,173 $0.000010 $0.43 $0.43 1x $0.43 6.28%
Series AA-2 357,361 $0.000010 $0.52 $0.52 1x $0.52 1.71%
To view HeartHero’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

HeartHero Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an automated external defibrillator (AED) intended to empower anyone, anywhere to save a life from sudden c
Other Devices and Supplies
Denver, CO
11 As of 2026

Danvers, MA
 

Mountain View, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HeartHero Competitors (5)

One of HeartHero’s 5 competitors is Abiomed, a Corporate Backed or Acquired company based in Danvers, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abiomed Corporate Backed or Acquired Danvers, MA
AliveCor Venture Capital-Backed Mountain View, CA
Element Science Venture Capital-Backed San Francisco, CA
Accuray Formerly VC-backed Madison, WI
Bardy Diagnostics Venture Capital-Backed Bellevue, WA
You’re viewing 5 of 5 competitors. Get the full list »

HeartHero Patents

HeartHero Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4694973-A1 Automated external defibrillator device with synchronized cardioversion and methods of use Pending 11-Apr-2023
US-20260273293-A1 Automated external defibrillator device with synchronized cardioversion and methods of use Pending 11-Apr-2023
WO-2024215773-A1 Automated external defibrillator device with synchronized cardioversion and methods of use Inactive 11-Apr-2023
WO-2024137945-A1 Cardiac pad wire connector Inactive 21-Dec-2022
EP-4587113-A2 Automated external defibrillator systems with deep sleep mode Pending 16-Sep-2022 A61N1/3975
To view HeartHero’s complete patent history, request access »

HeartHero Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HeartHero Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
AngelMD Angel Group Minority
COPIC Companies Corporation Minority
PIC Investment Group Family Office Minority
Colorado Venture Capital Authority Government
To view HeartHero’s complete investors history, request access »

HeartHero FAQs

  • When was HeartHero founded?

    HeartHero was founded in 2016.

  • Where is HeartHero headquartered?

    HeartHero is headquartered in Denver, CO.

  • What is the size of HeartHero?

    HeartHero has 11 total employees.

  • What industry is HeartHero in?

    HeartHero’s primary industry is Other Devices and Supplies.

  • Is HeartHero a private or public company?

    HeartHero is a Private company.

  • What is HeartHero’s current revenue?

    The current revenue for HeartHero is .

  • How much funding has HeartHero raised over time?

    HeartHero has raised $18.5M.

  • Who are HeartHero’s investors?

    AngelMD, COPIC Companies, PIC Investment Group, and Colorado Venture Capital Authority have invested in HeartHero.

  • Who are HeartHero’s competitors?

    Abiomed, AliveCor, Element Science, Accuray, and Bardy Diagnostics are competitors of HeartHero.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process